NuvoLase Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
2ndary - Open
NuvoLase General Information
Description
Developer of medical laser technology designed to address the unmet needs of clinicians and patients worldwide. The company's products include a specialized laser system that targets fungal infections located within and beneath the nail plate through the application of light energy without damaging surrounding tissue or skin, enabling medical professionals to use a dedicated tool to improve patient throughput and increase practice revenue while offering individuals a brief in-office procedure for clearer nails.
Contact Information
Website
www.toenailfunguslaser.comCorporate Office
- 10921 Wilshire Boulevard
- Unit 1011
- Los Angeles, CA 90024
- United States
Corporate Office
- 10921 Wilshire Boulevard
- Unit 1011
- Los Angeles, CA 90024
- United States
NuvoLase Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Open Market | 08-Mar-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 14-Feb-2017 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | Completed | Startup | ||||
| 1. Early Stage VC | 01-Dec-2014 | Completed | Startup |
NuvoLase Patents
NuvoLase Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2229980-A2 | Treatment of microbiological pathogens in a toe nail with antimicrobial light | Active | 16-Mar-2009 | ||
| EP-2229980-A3 | Treatment of microbiological pathogens in a toe nail with antimicrobial light | Active | 16-Mar-2009 | ||
| EP-2229980-B1 | Treatment of microbiological pathogens in a toe nail with antimicrobial light | Inactive | 16-Mar-2009 | ||
| US-20100234925-A1 | Treatment of microbiological pathogens in a toe nail with antimicrobial light | Inactive | 16-Mar-2009 | A61N5/0616 |
NuvoLase Investments & Acquisitions (2)
NuvoLase’s most recent deal was a Merger/Acquisition with PinPointe USA. The deal was made on 13-Sep-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PinPointe USA | 13-Sep-2011 | Merger/Acquisition | Therapeutic Devices | ||
| PathoLase | 12-Sep-2011 | Buyout/LBO | Other Devices and Supplies |
NuvoLase FAQs
-
When was NuvoLase founded?
NuvoLase was founded in 2011.
-
Where is NuvoLase headquartered?
NuvoLase is headquartered in Los Angeles, CA.
-
What industry is NuvoLase in?
NuvoLase’s primary industry is Other Devices and Supplies.
-
Is NuvoLase a private or public company?
NuvoLase is a Private company.
-
What is NuvoLase’s current revenue?
The current revenue for NuvoLase is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process